Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Monogram Technologies Inc.

Market Cap 244M 211M 194M 182M 340M 23.17B 346M 2.29B 893M 11.28B 915M 895M 39.05B P/E Ratio 2023
-5.61x
P/E Ratio 2024 -4.73x
Enterprise Value 228M 197M 182M 170M 319M 21.72B 324M 2.15B 837M 10.57B 857M 839M 36.6B EV / Sales 2023
257,522,925x
EV / Sales 2024 -
Free-Float
64.74%
Yield 2023 *
-
Yield 2024 -

Last Transcript: Monogram Technologies Inc.

1 year 2.56
Extreme 2.56
6.42
3 years 1.53
Extreme 1.53
6.55
5 years 1.53
Extreme 1.53
48.99
10 years 1.53
Extreme 1.53
48.99
Date Insider Type Main position Quantity % Market Cap.
07/10/25Issuer sale

Founder

5,007,622 12.3242%
07/10/25Issuer sale

Director

8,000 0.0197%
07/10/25Issuer sale

Chief Financial Officer

411,385 1.0125%
Change 5-day change 1-year change 3-year change Capi.($)
-1.80%-.--%+126.84%+57.89% 244M
+2.24%+2.40%-17.74%+11.82% 117B
-0.31%-1.22%+2.12%-4.39% 12.86B
+1.74%+1.31%+29.75%+89.21% 7.29B
+1.87%-3.51%-46.74%-69.06% 4.12B
+2.06%+5.59%+11.04%+33.01% 2.49B
+5.46%+10.30%-16.96%-14.78% 1.7B
+1.67%-6.39%+3.63%-11.43% 1.63B
-8.89%-8.45%+165.17%+112.14% 1.49B
Average +0.48%+0.95%+28.57%+22.71% 16.56B
Weighted average by Cap. +2.00%+1.38%-11.71%+12.85%

Financials

2023 2024
Net sales 0.36 0.32 0.29 0.27 0.51 34.69 0.52 3.43 1.34 16.89 1.37 1.34 58.47 -
Net income -13.75M -11.87M -10.94M -10.24M -19.19M -1.31B -19.49M -129M -50.36M -636M -51.59M -50.49M -2.2B -16.33M -14.1M -13M -12.16M -22.8M -1.55B -23.15M -153M -59.83M -755M -61.28M -59.97M -2.62B
Net Debt -13.1M -11.31M -10.42M -9.76M -18.29M -1.24B -18.57M -123M -47.99M -606M -49.15M -48.11M -2.1B -15.33M -13.24M -12.2M -11.42M -21.4M -1.46B -21.73M -144M -56.16M -709M -57.52M -56.29M -2.46B
Logo Monogram Technologies Inc.
Monogram Technologies Inc. is an artificial intelligence (AI)-driven robotics company focused on improving human health, with an initial focus on orthopedic surgery. The Company is developing a product solution architecture to enable patient-optimized orthopedic implants at scale by combining 3D printing, advanced machine vision, AI and robotics. The Company's mBos precision robotic surgical system is designed to autonomously execute optimized paths for high-precision insertion of its FDA-cleared mPress press-fit implants. The Company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. It is also exploring other clinical and commercial applications for mBos with mVision navigation. Its mVision technology leverages AI-trained algorithms to track pre-identified objects in real-time.
Employees
27
  1. Stock Market
  2. Stocks
  3. MGRM Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!